Search

everythinglearnresearchcommunity

for

Search:↓

Latanoprost can make eyelashes longer, thicker, and darker.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

Aconiti Ciliare Tuber extract may help hair grow by activating a specific cell signaling pathway.

Different types of hair loss require specific treatments, and new treatments are being developed.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Dermoscopy is useful for identifying and tracking different types of hair loss without scarring.

An imbalanced gut and lack of biotin can cause hair loss in mice.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Prompt diagnosis and treatment of hair tourniquet syndrome involving the uvula are crucial to prevent severe complications.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

New hair loss treatments could be improved by using combined biological markers.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

A systematic approach is crucial for managing hair loss in women.

Epinephrine does not significantly affect the severity of hair loss after surgery.